Targeting Her2/Neu in Uterine Serous Carcinoma: A Paradigm Shift in Management

Oncotarget - United States
doi 10.18632/oncotarget.26413
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Pathogenesis and Clinical Management of Uterine Serous Carcinoma

Cancers
Cancer ResearchOncology
2020English

Study of Her2/Neu Expression in 100 Cases of Uterine and Cervical Carcinoma as a Prognostic Marker

Annals of Pathology and Laboratory Medicine
2018English

Activating Mutations in HER2 : Neu Opportunities and Neu Challenges

Cancer Discovery
Oncology
2013English

Spectral Fluorescence Molecular Imaging of Lung Metastases Targeting HER2/neu

Clinical Cancer Research
Cancer ResearchOncology
2007English

Selective Excavation: A Paradigm Shift in Carious Lesion Management.

International Journal of Advanced Research
2018English

HER2 (EGFR2; ErbB2; Neu)

Science-Business eXchange
2013English

Shift in Paradigm

Global Perspectives on Development Administration and Cultural Change
2017English

Her2/Neu Protein Expression in Colorectal Cancer

Journal of Evolution of Medical and Dental Sciences
2019English

Metastatic Carcinoma of Endometrium From Primary Ovarian Serous Carcinoma Mimicking a Primary Uterine Tumour

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy